Schedule 13G ownership disclosure

NEUROSENSE THERAPEUTICS LTD

Security class unavailable · CUSIP: M74240108

Event date: 2022-01-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
3.8400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-23-020257
Form type
SC 13G
Filer
NeuroSense Therapeutics Ltd.
CIK
CIK 1875091
Filed
Mar 15, 2023
Reporting period
Jan 11, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub